货号:GS40792
Vipalanebart (LY3451838) is an investigational humanized monoclonal antibody of the IgG4κ isotype that targets the pituitary adenylate cyclase-activating polypeptide type I receptor (ADCYAP1R1, also known as PAC1). It is being developed primarily for the prevention and treatment of migraine, aiming to block the PACAP signaling pathway, which is critically involved in migraine pathophysiology.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯